Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Gynecology

Free Subscription 06.02.2023 2 Acta Obstet Gynecol Scand 1 AJR Am J Roentgenol 7 Am J Obstet Gynecol 1 Aust N Z J Obstet Gynaecol 2 BMC Cancer 3 BMJ 1 Br J Cancer 1 Eur J Cancer 4 Eur J Obstet Gynecol Reprod Biol 2 Fertil Steril 2 Gynecol Endocrinol 8 Gynecol Oncol 4 Hum Reprod 14 Int J Gynaecol Obstet 4 J Clin Endocrinol Metab 2 J Clin Oncol 1 J Urol 5 Obstet Gynecol 1 Oncogene 1 PLoS Med 5 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Obstet Gynecol Scand

1. VISTAD I, Bjorge L
   Advanced endometrial cancer: New medical treatment options on the horizon.
   Acta Obstet Gynecol Scand. 2023;102:128-129.
   PubMed        
   
   
2. DE DECKER K, Wenzel HHB, Bart J, van der Aa MA, et al
   Stage, treatment and survival of low-grade serous ovarian carcinoma in the Netherlands-A nationwide study.
   Acta Obstet Gynecol Scand. 2023 Feb 3. doi: 10.1111/aogs.14518.
   PubMed         Abstract available
   
   

   
   AJR Am J Roentgenol

3. ZHANG Q, Dai X, Li W
   Systematic Review and Meta-Analysis of O-RADS Ultrasound and O-RADS MRI for Risk Assessment of Ovarian and Adnexal Lesions.
   AJR Am J Roentgenol. 2023 Feb 1. doi: 10.2214/AJR.22.28396.
   PubMed         Abstract available
   
   

   
   Am J Obstet Gynecol

4. ALCOVER N, Regiroli G, Benachi A, Vauloup-Fellous C, et al
   Systematic review and synthesis of stillbirths and late miscarriages following SARS-CoV-2 infections.
   Am J Obstet Gynecol. 2023 Jan 24:S0002-9378(23)00026.
   PubMed         Abstract available
   
   
5. CAO X, Chen S, Xu C
   Proinflammatory changes in the maternal circulation, maternalefetal interface, and placental transcriptome in preterm birth: a comment.
   Am J Obstet Gynecol. 2023 Jan 30:S0002-9378(23)00068.
   PubMed        
   
   
6. ROBERTS DJ, Baergen RN, Boyd TK, Carreon CK, et al
   Neonatologist responsibility to ensure placentas are received for pathologic examination - response to comment for Criteria for placental examination for obstetric and neonatal providers.
   Am J Obstet Gynecol. 2023 Jan 30:S0002-9378(23)00067.
   PubMed        
   
   
7. SHI P, Liang H, Hou Y, Chen D, et al
   The uncertainty of copy number variants: pregnancy decisions and clinical follow up.
   Am J Obstet Gynecol. 2023 Jan 27:S0002-9378(23)00062.
   PubMed         Abstract available
   
   
8. BALHOTRA K, Roach C, Al-Kouatly HB, Minkoff H, et al
   Association of anti-hypertensive medication at discharge with readmission for postpartum preeclampsia.
   Am J Obstet Gynecol. 2023 Jan 27:S0002-9378(23)00060.
   PubMed        
   
   
9. MARCHANTE M, Buigues A, Ramirez-Martin N, Martinez J, et al
   Single intraovarian dose of stem cell- and platelet-secreted factors mitigates age-related ovarian infertility in a murine model.
   Am J Obstet Gynecol. 2023 Jan 24:S0002-9378(23)00025.
   PubMed         Abstract available
   
   
10. MUNRO MG, Mast AE, Powers JM, Kouides PA, et al
    The Relationship between Heavy Menstrual Bleeding, Iron Deficiency, and Iron Deficiency Anemia.
    Am J Obstet Gynecol. 2023 Jan 24:S0002-9378(23)00024.
    PubMed         Abstract available
    
    

    
    Aust N Z J Obstet Gynaecol

11. SKALECKI S, Lawford H, Gardener G, Coory M, et al
    My Baby's Movements: An assessment of the effectiveness of the My Baby's Movements phone program in reducing late-gestation stillbirth rates.
    Aust N Z J Obstet Gynaecol. 2023 Jan 30. doi: 10.1111/ajo.13647.
    PubMed         Abstract available
    
    

    
    BMC Cancer

12. HEEMELAAR JC, Heemelaar S, Hertel SN, Jukema JW, et al
    Cardiac and obstetric outcomes of pregnancies for women after cardiotoxic therapy in childhood: a single center observational study.
    BMC Cancer. 2023;23:115.
    PubMed         Abstract available
    
    
13. CHAI H, Pan C, Zhang M, Huo H, et al
    Histone methyltransferase SETD1A interacts with notch and promotes notch transactivation to augment ovarian cancer development.
    BMC Cancer. 2023;23:96.
    PubMed         Abstract available
    
    

    
    BMJ

14. TORJESEN I
    Ovarian cancer: Loyalty card data could help identify cases sooner.
    BMJ. 2023;380:227.
    PubMed        
    
    
15. CRUMP C, Sundquist J, McLaughlin MA, Dolan SM, et al
    Adverse pregnancy outcomes and long term risk of ischemic heart disease in mothers: national cohort and co-sibling study.
    BMJ. 2023;380:e072112.
    PubMed         Abstract available
    
    
16. THORNTON J
    Demand for abortions surges as contraception services shrink and cost of living rises.
    BMJ. 2023;380:237.
    PubMed        
    
    

    
    Br J Cancer

17. KRALJ J, Pernar Kovac M, Dabelic S, Polancec DS, et al
    Transcriptome analysis of newly established carboplatin-resistant ovarian cancer cell model reveals genes shared by drug resistance and drug-induced EMT.
    Br J Cancer. 2023 Jan 30. doi: 10.1038/s41416-023-02140.
    PubMed         Abstract available
    
    

    
    Eur J Cancer

18. CUEVA JF, Palacio I, Churruca C, Herrero A, et al
    Real-world safety and effectiveness of maintenance niraparib for platinum-sensitive recurrent ovarian cancer: A GEICO retrospective observational study within the Spanish expanded-access programme.
    Eur J Cancer. 2022;182:3-14.
    PubMed         Abstract available
    
    

    
    Eur J Obstet Gynecol Reprod Biol

19. GOVENDER S, Nayak NR, Nandlal L, Naicker T, et al
    Gene polymorphisms within regions of complement component C1q in HIV associated preeclampsia.
    Eur J Obstet Gynecol Reprod Biol. 2023;282:133-139.
    PubMed         Abstract available
    
    
20. CASARIN J, Ghezzi F, Dri M, Granato V, et al
    Laparoscopic subtotal hysterectomy followed by in-bag transvaginal corpus uteri morcellation and extraction: A case series.
    Eur J Obstet Gynecol Reprod Biol. 2023;282:124-127.
    PubMed         Abstract available
    
    
21. SECKIN KD, Kadirogullari P
    Is dienogest a convenient treatment option for cesarean scar endometriosis or should it be treated surgically?
    Eur J Obstet Gynecol Reprod Biol. 2023;282:110-115.
    PubMed         Abstract available
    
    
22. BESER DM, Oluklu D, Hendem DU, Yildirim M, et al
    Fetal thymic-thoracic ratio in pregnancies with familial Mediterranean fever.
    Eur J Obstet Gynecol Reprod Biol. 2023;282:105-109.
    PubMed         Abstract available
    
    

    
    Fertil Steril

23. KLEIN MEULEMAN SJM, Post B, Vissers J, de Leeuw RA, et al
    Uterine niches and infertility - challenge for the future.
    Fertil Steril. 2023 Jan 30:S0015-0282(23)00080.
    PubMed        
    
    
24. LI PS, Peng XM, Niu XX, Xu L, et al
    Efficacy of acupuncture for endometriosis-associated pain: A multicenter randomized single-blind placebo-controlled trial.
    Fertil Steril. 2023 Jan 27:S0015-0282(23)00072.
    PubMed         Abstract available
    
    

    
    Gynecol Endocrinol

25. VANNUCCINI S, Petraglia F
    Adenomyosis: is an endocrine-related uterine dysfunction?
    Gynecol Endocrinol. 2023 Feb 3:2172156. doi: 10.1080/09513590.2023.2172156.
    PubMed        
    
    
26. YANG H, Chen Y, Liu C
    Triglyceride-glucose index is associated with metabolic syndrome in women with polycystic ovary syndrome.
    Gynecol Endocrinol. 2023 Jan 28:2172154. doi: 10.1080/09513590.2023.2172154.
    PubMed         Abstract available
    
    

    
    Gynecol Oncol

27. DAVIDSON TM, Lebreton CL, Hendricksen AEW, Atkinson HJ, et al
    Results of TRIO-15, a multicenter, open-label, phase II study of the efficacy and safety of ganitumab in patients with recurrent platinum-sensitive ovarian cancer.
    Gynecol Oncol. 2023;170:221-228.
    PubMed         Abstract available
    
    
28. ZHANG Y, Yang R, Xu C, Zhang Y, et al
    Risk stratification and molecular heterogeneity of endometrial cancer and expression profile of TIM-3: A retrospective cohort study.
    Gynecol Oncol. 2023;170:210-220.
    PubMed         Abstract available
    
    
29. HAIGHT PJ, Barrington DA, Graves SM, Piver RN, et al
    Safety and feasibility of same-day discharge following minimally invasive hysterectomy in the morbidly obese patient population.
    Gynecol Oncol. 2023;170:203-209.
    PubMed         Abstract available
    
    
30. CIBULA D, Akilli H, Jarkovsky J, van Lonkhuijzen L, et al
    Role of adjuvant therapy in intermediate-risk cervical cancer patients - Subanalyses of the SCCAN study.
    Gynecol Oncol. 2023;170:195-202.
    PubMed         Abstract available
    
    
31. FERRON G, De Rauglaudre G, Becourt S, Delanoy N, et al
    Neoadjuvant chemotherapy with or without nintedanib for advanced epithelial ovarian cancer: Lessons from the GINECO double-blind randomized phase II CHIVA trial.
    Gynecol Oncol. 2023;170:186-194.
    PubMed         Abstract available
    
    
32. BRAGA A, Andrade T, do Carmo Borges de Souza M, Campos V, et al
    Presentation, medical complications and development of gestational trophoblastic neoplasia of hydatidiform mole after intracytoplasmic sperm injection as compared to hydatidiform mole after spontaneous conception - a retrospective cohort study and lit
    Gynecol Oncol. 2023;170:179-185.
    PubMed         Abstract available
    
    
33. HAN C, McNamara B, Bellone S, Harold J, et al
    The Poly (ADP-ribose) polymerase inhibitor olaparib and pan-ErbB inhibitor neratinib are highly synergistic in HER2 overexpressing epithelial ovarian carcinoma in vitro and in vivo.
    Gynecol Oncol. 2023;170:172-178.
    PubMed         Abstract available
    
    
34. STRAUBHAR AM, Stroup C, de Bear O, Dalton L, et al
    Provider compliance with a tailored opioid prescribing calculator in gynecologic surgery.
    Gynecol Oncol. 2023;170:229-233.
    PubMed         Abstract available
    
    

    
    Hum Reprod

35. GROSBOIS J, Bailie EC, Kelsey TW, Anderson RA, et al
    Spatio-temporal remodelling of the composition and architecture of the human ovarian cortical extracellular matrix during in vitro culture.
    Hum Reprod. 2023 Jan 31:dead008. doi: 10.1093.
    PubMed         Abstract available
    
    
36. FRIIS WANG N, Bogstad JW, Pors SE, Petersen MR, et al
    Eight weeks of androgen priming by daily low-dose hCG injections before ICSI treatment in women with low ovarian reserve.
    Hum Reprod. 2023 Jan 31:dead012. doi: 10.1093.
    PubMed         Abstract available
    
    
37. 
    Correction: Investigation of the effects of heparin and low molecular weight heparin on E-cadherin and laminin expressions in rat pregnancy by immunohistochemistry.
    Hum Reprod. 2023 Feb 1:dead022. doi: 10.1093.
    PubMed        
    
    
38. DEVOS M, Diaz Vidal P, Bouziotis J, Anckaert E, et al
    Impact of first chemotherapy exposure on follicle activation and survival in human cryopreserved ovarian tissue.
    Hum Reprod. 2023 Feb 1:dead013. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Int J Gynaecol Obstet

39. RODRIGUEZ GF, Vilarino V, Agasse E, Galli J, et al
    An Analysis of Changing U.S. Practice Advisory Guidelines on COVID-19 Vaccine Uptake in Pregnancy.
    Int J Gynaecol Obstet. 2023 Jan 27. doi: 10.1002/ijgo.14697.
    PubMed        
    
    
40. GAUTHIER-MOULINIER H, Daouda N, Rabilloud M, Nguyen KA, et al
    Outcomes of pregnancies with preterm premature rupture of membranes occurring before 24 weeks of gestation: An eleven-year observational study.
    Int J Gynaecol Obstet. 2023 Jan 27. doi: 10.1002/ijgo.14700.
    PubMed         Abstract available
    
    
41. SCHNEIDMAN J, Lee T, Sauve L, Brophy J, et al
    Type and timing of antiretroviral therapy during pregnancy: impact on risk of preterm delivery and small-for-gestational-age births in Canada, a retrospective cohort study.
    Int J Gynaecol Obstet. 2023 Jan 27. doi: 10.1002/ijgo.14705.
    PubMed         Abstract available
    
    
42. MAROYI R, Nyakio O, Buhendwa C, Mukanga O, et al
    Experience on Trial of Labor and Vaginal Delivery after Two Previous Cesarean Sections: A Cohort Study from a Limited-Resource Setting.
    Int J Gynaecol Obstet. 2023 Jan 27. doi: 10.1002/ijgo.14665.
    PubMed         Abstract available
    
    
43. XU T, Zhang L, Jiang Y, Wan Y, et al
    Clinical characteristics and serum CA19-9 combined with HE4 are valuable in diagnosing endometriosis-associated ovarian cancer.
    Int J Gynaecol Obstet. 2023 Jan 27. doi: 10.1002/ijgo.14695.
    PubMed         Abstract available
    
    
44. ALEKSEENKOVA EN, Babakov VN, Selkov SA, Di Renzo GC, et al
    Maternal IGFs and IGFBPs for macrosomia prediction in diabetic and non-diabetic pregnancy: a prospective study.
    Int J Gynaecol Obstet. 2023 Jan 27. doi: 10.1002/ijgo.14696.
    PubMed         Abstract available
    
    
45. ZOUAGHI C, Chaouch MA, Sanchez S, Zouaghi S, et al
    Hysteroscopy after conservative surgical treatment of severe postpartum hemorrhage due to uterine atony: A systematic literature review.
    Int J Gynaecol Obstet. 2023 Jan 29. doi: 10.1002/ijgo.14704.
    PubMed         Abstract available
    
    
46. FERNANDES DA ANUNCIACAO BHS, Azevedo MJM, de Lurdes Ferreira Lobo Pereira M
    Knowledge, attitudes, and practices of prenatal care practitioners regarding oral health in pregnancy - a systematic review.
    Int J Gynaecol Obstet. 2023 Jan 29. doi: 10.1002/ijgo.14703.
    PubMed         Abstract available
    
    
47. HUANG Y, Zhou T, Li Y, Gao X, et al
    Primary Caesarean scar choriocarcinoma: A case series and literature review.
    Int J Gynaecol Obstet. 2023 Jan 30. doi: 10.1002/ijgo.14702.
    PubMed         Abstract available
    
    
48. KAUR M, Kaur R, Chhabra K, Khetarpal P, et al
    "Maternal Candidate Gene Variants, Epigenetic factors and susceptibility to idiopathic Recurrent Pregnancy Loss (iRPL) - A systematic review".
    Int J Gynaecol Obstet. 2023 Jan 30. doi: 10.1002/ijgo.14701.
    PubMed         Abstract available
    
    
49. HU Y, Chen W, Kong C, Lin G, et al
    Prediction of Placental Accreta Spectrum with nomogram combining radiomic and clinical factors: A novel developed and validated integrative model.
    Int J Gynaecol Obstet. 2023 Feb 2. doi: 10.1002/ijgo.14710.
    PubMed         Abstract available
    
    
50. ZHANG Y, Xu X, Xie Z, Li Y, et al
    Identifying symptom clusters among pregnant women during early and late pregnancy.
    Int J Gynaecol Obstet. 2023 Feb 2. doi: 10.1002/ijgo.14712.
    PubMed         Abstract available
    
    
51. KALRA K, Jain S, Rajaram S, Gupta B, et al
    A novel technique of Vagino-hysteroscopy using Alginate Gel Interface: a proof of concept study.
    Int J Gynaecol Obstet. 2023 Feb 2. doi: 10.1002/ijgo.14709.
    PubMed         Abstract available
    
    
52. LAGE ALVES AL, Braga da Silva J, de Oliveira Santos M, Belo Lopes AV, et al
    Uterine tamponade in postpartum hemorrhage with handmade balloons: Comparison of manufacturing, infusion, and total times.
    Int J Gynaecol Obstet. 2023 Feb 2. doi: 10.1002/ijgo.14711.
    PubMed         Abstract available
    
    

    
    J Clin Endocrinol Metab

53. ZHANG JH, Chen JH, Guo B, Fang Y, et al
    Recent insights into non-coding RNAs in primary ovarian insufficiency: focus on mechanisms and treatments.
    J Clin Endocrinol Metab. 2023 Feb 3:dgad070. doi: 10.1210.
    PubMed         Abstract available
    
    
54. JOHNSON KA, Martin N, Nappi RE, Neal-Perry G, et al
    Efficacy and Safety of Fezolinetant in Moderate-to-Severe Vasomotor Symptoms Associated With Menopause: A Phase 3 RCT.
    J Clin Endocrinol Metab. 2023 Feb 3:dgad058. doi: 10.1210.
    PubMed         Abstract available
    
    
55. 
    Correction to "Low Circulating Levels of miR-451a in Girls with Polycystic Ovary Syndrome: Different Effects of Randomized Treatments".
    J Clin Endocrinol Metab. 2023 Feb 3:dgad062. doi: 10.1210.
    PubMed        
    
    
56. WU S, Li L, Hu KL, Wang S, et al
    A Prediction Model of Gestational Diabetes Mellitus Based on OGTT in Early Pregnancy: A Prospective Cohort Study.
    J Clin Endocrinol Metab. 2023 Feb 1:dgad052. doi: 10.1210.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

57. MARCHETTI C, Fagotti A, Scambia G
    Rucaparib Maintenance in Upfront Ovarian Cancer: The Long-Lasting Challenge of Predicting Response to Poly (ADP-ribose) Polymerase Inhibitors.
    J Clin Oncol. 2022 Oct 6:JCO2201585. doi: 10.1200/JCO.22.01585.
    PubMed        
    
    
58. PFISTERER J, Joly F, Kristensen G, Rau J, et al
    Optimal Treatment Duration of Bevacizumab as Front-Line Therapy for Advanced Ovarian Cancer: AGO-OVAR 17 BOOST/GINECO OV118/ENGOT Ov-15 Open-Label Randomized Phase III Trial.
    J Clin Oncol. 2022 Nov 4:JCO2201010. doi: 10.1200/JCO.22.01010.
    PubMed         Abstract available
    
    

    
    J Urol

59. LIGON MM, Liang B, Lenger SM, Parameswaran P, et al
    Bladder Mucosal Cystitis Cystica Lesions are Tertiary Lymphoid Tissues that Correlate with Recurrent UTI Frequency in Postmenopausal Women.
    J Urol. 2023 Jan 30:101097JU0000000000003196. doi: 10.1097/JU.0000000000003196.
    PubMed         Abstract available
    
    

    
    Obstet Gynecol

60. ZHOU F, Lindley MC, Lee JT, Jatlaoui TC, et al
    Association Between Influenza Vaccination During Pregnancy and Infant Influenza Vaccination.
    Obstet Gynecol. 2023 Jan 17. doi: 10.1097/AOG.0000000000005101.
    PubMed         Abstract available
    
    
61. EINERSON BD, Kennedy A, Silver RM, Branch DW, et al
    Ultrasonography of the Explanted Uterus in Placenta Accreta Spectrum: Correlation With Intraoperative Findings and Gross Pathology.
    Obstet Gynecol. 2023 Feb 2. doi: 10.1097/AOG.0000000000005075.
    PubMed         Abstract available
    
    
62. LIU Z, Geng Y, Huang Y, Hu R, et al
    Letrozole Compared With Clomiphene Citrate for Polycystic Ovarian Syndrome: A Systematic Review and Meta-analysis.
    Obstet Gynecol. 2023 Feb 2. doi: 10.1097/AOG.0000000000005070.
    PubMed         Abstract available
    
    
63. MORGAN JA, Biggio JR Jr, Martin JK, Mussarat N, et al
    Pregnancy Outcomes in Patients After Completion of the mRNA Coronavirus Disease 2019 (COVID-19) Vaccination Series Compared With Unvaccinated Patients.
    Obstet Gynecol. 2023 Feb 2. doi: 10.1097/AOG.0000000000005072.
    PubMed         Abstract available
    
    
64. BAKER CC, Smith E, Creinin MD, Moayedi G, et al
    Texas Senate Bill 8 and Abortion Experiences in Patients With Fetal Diagnoses: A Qualitative Analysis.
    Obstet Gynecol. 2023 Feb 2. doi: 10.1097/AOG.0000000000005071.
    PubMed         Abstract available
    
    

    
    Oncogene

65. NI M, Li J, Zhao H, Xu F, et al
    BRD4 inhibition sensitizes cervical cancer to radiotherapy by attenuating DNA repair.
    Oncogene. 2021 Mar 12. pii: 10.1038/s41388-021-01735.
    PubMed         Abstract available
    
    

    
    PLoS Med

66. YANG L, Boily MC, Ronn MM, Obiri-Yeboah D, et al
    Regional and country-level trends in cervical cancer screening coverage in sub-Saharan Africa: A systematic analysis of population-based surveys (2000-2020).
    PLoS Med. 2023;20:e1004143.
    PubMed         Abstract available
    
    

    
    PLoS One

67. RAO JS, Kobetz E, Yu H, Baeker-Bispo J, et al
    Partially Recursively Induced Structured Moderation (PRISM) for modeling racial differences in endometrial cancer survival.
    PLoS One. 2023;18:e0268221.
    PubMed         Abstract available
    
    
68. DE FOUW M, Stroeken Y, Niwagaba B, Musheshe M, et al
    Involving men in cervical cancer prevention; a qualitative enquiry into male perspectives on screening and HPV vaccination in Mid-Western Uganda.
    PLoS One. 2023;18:e0280052.
    PubMed         Abstract available
    
    
69. CARMICHAEL MM, Alchaar I, Davis KA, Krevosky MK, et al
    The small heat shock protein alphaB-Crystallin protects versus withaferin A-induced apoptosis and confers a more metastatic phenotype in cisplatin-resistant ovarian cancer cells.
    PLoS One. 2023;18:e0281009.
    PubMed         Abstract available
    
    
70. KRAUT R, Carvallo FD, Golonka R, Campbell SM, et al
    Scoping review of cytolytic vaginosis literature.
    PLoS One. 2023;18:e0280954.
    PubMed         Abstract available
    
    
71. OKUNADE KS, Badmos KB, Okoro AC, Ademuyiwa IY, et al
    Comparative Assessment of p16/Ki-67 Dual Staining Technology for cervical cancer screening in women living with HIV (COMPASS-DUST)-Study protocol.
    PLoS One. 2023;18:e0278077.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Gynecology is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: